Casey C. May, PharmD, BCCCP, FNCS

Associate Professor @osu_pharmacy | PGY1 RPD & 🧠Neurocritical Care Pharmacist @OSUWexMed | R419 @UKPharmRes |@UK_COP|@UVA| Wife | Mother | Tweets are my own

[Casey C. May, PharmD, BCCCP, FNCS @CaseyMayPharmD]

Overjoyed to share this labor of love! ❤️

Multicenter Comparison of Safety & Efficacy of Clopidogrel (DAPT-C) vs Ticagrelor (DAPT-T) for Neuroendovacular Stents 👇
https://t.co/BWKxgmWsYG

@NeurocritCareJ @neurocritical

#AcademicTwitter #TwitteRx

[Nick Panos @NG_Panos]

Sharing an awesome review of antiseizure medication dosing and monitoring in the ICU

https://t.co/xHuJy85WRA

[SCCM Neuroscience Section @SCCM_Neuro]

SAVE THE DATE!

Join us for our next Section webinar on Thursday, September 24, 3-4PM CST.

"White Coats, Wider Horizons: Research, Innovation, & Leadership Success from Private Practice"

Zoom link on Connect.🧠

#SCCMNeuro #NeuroICU #NeuroX #NeuroTwitter

[Stephan A Mayer @stephanamayer]

Mobile stroke units are part of the solution for the #CodeICH movement to elevate ICH care to the same high standards that already exist for AIS

[Neurocritical Care Society @neurocritical]

ICH care is evolving…are you equipped to enact change? 🧠
Join our virtual masterclass May 28 to learn how to integrate new advances in your practice and review evidence-based ICH management, practical bedside strategies and emerging therapies. https://t.co/baXx25iFxV

[SCCMohio @SCCMohio]

Our Spring Symposium is TOMORROW! After programming concludes, stick around for networking at Pinstripes in Beachwood. We can't wait to see you all there!

[Neurocritical Care Society @neurocritical]

ICH care is evolving…are equipped to enact change? 🧠
Join our virtual masterclass May 28 to learn how to integrate new advances in your practice and review evidence-based ICH management, practical bedside strategies, and emerging therapies.

https://t.co/baXx25iFxV

[Jenna Taglienti @jenna_taglienti]

I wrote this in a moment I never would have chosen. A sudden pause that made me see my life clearly.

The meaning of our work is profound. This experience simply helped me see more clearly what matters most.

“Time is Finite” JAMA

https://t.co/IwkKdyeEWx

[Neurocritical Care Society @neurocritical]

New ep Introducing the APP Voice with Tom Lawson, PhD, ACNPBC, FNCS. Tom reflects on his path into neurocritical care and what keeps him engaged in the specialty’s unique blend of neurology and ICU medicine.

Listen here: https://t.co/64FOjOEoE3

[NEJM @NEJM]

In the phase 3 OCEANIC-STROKE trial involving patients with noncardioembolic ischemic stroke or high-risk TIA, asundexian added to antiplatelet therapy led to a lower risk of ischemic stroke without increasing major bleeding. Full trial results: https://t.co/UPJGedYXFe

Editorial: Asundexian for Noncardioembolic Ischemic Stroke https://t.co/V1dVNbx4T8

[SCCMohio @SCCMohio]

It's not too late to register for our in-person Spring Symposium! You don't want to miss out- register now on our website or using this link: https://t.co/KX0GVur43V

[Neurocritical Care Society @neurocritical]

Join the NCS Pharmacy Section on Monday, April 6 at 1 PM CT for this month's journal club and chat with colleagues on social with #NCSPharmJC. Log in to your NCS account and visit the Pharmacy Section: https://t.co/GjtOz5uBh8

[Neurocritical Care Society @neurocritical]

NCS invites you to submit a research abstract for the 24th Annual Meeting in Seattle, Washington. Abstracts must be submitted by April 29. Learn more: https://t.co/KxOKueQceL

[SCCM Neuroscience Section @SCCM_Neuro]

Dr. Hana Nobleza moderated spirited debates on Code ICH (@stephanamayer vs Neeraj Naval) & 0° head positioning in stroke (Anne Alexandrov vs Archana Hinduja)!🧠

#SCCMNeuro #NeuroICU #NeuroX #NeuroTwitter

[Neurocritical Care Society @neurocritical]

The Call for Proposals is officially open for Concurrent Sessions and Workshops at the 24th Annual Meeting! Shape this year’s scientific and educational program by submitting your innovative ideas and expertise. Now is your chance: ➡️https://t.co/VlyyMs2Tyn

[Casey C. May, PharmD, BCCCP, FNCS @CaseyMayPharmD]

Let us know your thoughts!
Based on these results what would you do?

[Casey C. May, PharmD, BCCCP, FNCS @CaseyMayPharmD]

Alyssia Calhoun, a PGY2 Critical Care Resident from UChicago Med will be presenting on the ASSET-IT Trial! Let's Go!
Tao C, et al. @NEJM. 2025;393(12):1191-1201.
@ETNCCRX @neurocritical @karenccrx @KLFrx @AJWPharm @NG_Panos @KeatonSmetana
#NCSPharmJC

[Casey C. May, PharmD, BCCCP, FNCS @CaseyMayPharmD]

Key Takeaway: ASSET-IT showed improved mRS 0–1 with early tirofiban after IVT in non-cardioembolic AIS.
#NCSPharmJC